Clinical Trial Update: A Study of Adebrelimab in Combination with Chemo with or Without Bevacizumab Neoadjuvant Therapy for Resectable NSCLC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating Adebrelimab in combination with chemotherapy, with or without Bevacizumab, as neoadjuvant therapy for resectable non-smal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: The First Affiliated Hospital of Guangzhou Medical University | Conditions: Resectable Lung Non-Small Cell Carcinoma | Phase 2 | Status: RECRUITING